Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1948 1
1950 2
1951 1
1952 2
1953 3
1954 3
1956 1
1957 1
1958 1
1961 4
1962 3
1963 21
1964 19
1965 28
1966 19
1967 19
1968 49
1969 42
1970 38
1971 33
1972 23
1973 31
1974 25
1975 33
1976 35
1977 48
1978 50
1979 51
1980 67
1981 79
1982 89
1983 94
1984 108
1985 91
1986 101
1987 97
1988 125
1989 162
1990 126
1991 148
1992 178
1993 182
1994 183
1995 213
1996 200
1997 209
1998 226
1999 272
2000 280
2001 281
2002 302
2003 329
2004 321
2005 379
2006 377
2007 428
2008 386
2009 407
2010 438
2011 460
2012 534
2013 583
2014 545
2015 587
2016 578
2017 644
2018 646
2019 661
2020 401
Text availability
Article attribute
Article type
Publication date

Search Results

12,016 results
Results by year
Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. Among authors: Tanaka Y. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
Inoue S, Hirota Y, Ueno T, Fukui Y, Yoshida E, Hayashi T, Kojima S, Takeyama R, Hashimoto T, Kiyono T, Ikemura M, Taguchi A, Tanaka T, Tanaka Y, Sakata S, Takeuchi K, Muraoka A, Osuka S, Saito T, Oda K, Osuga Y, Terao Y, Kawazu M, Mano H. Inoue S, et al. Among authors: Tanaka T, Tanaka Y. Nat Commun. 2019 Dec 19;10(1):5785. doi: 10.1038/s41467-019-13708-y. Nat Commun. 2019. PMID: 31857578 Free PMC article. Clinical Trial.
Broad Heterochromatic Domains Open in Gonocyte Development Prior to De Novo DNA Methylation.
Yamanaka S, Nishihara H, Toh H, Eijy Nagai LA, Hashimoto K, Park SJ, Shibuya A, Suzuki AM, Tanaka Y, Nakai K, Carninci P, Sasaki H, Siomi H. Yamanaka S, et al. Among authors: Tanaka Y. Dev Cell. 2019 Oct 7;51(1):21-34.e5. doi: 10.1016/j.devcel.2019.07.023. Epub 2019 Aug 29. Dev Cell. 2019. PMID: 31474564
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, Katano H, Hishima T, Kobayashi S, Nakano K, Nakashima M, Iwanaga M, Utsunomiya A, Tanaka Y, Okada S, Tsukasaki K, Tobinai K, Araki K, Watanabe T, Uchimaru K. Yamagishi M, et al. Among authors: Tanaka Y. Cell Rep. 2019 Nov 19;29(8):2321-2337.e7. doi: 10.1016/j.celrep.2019.10.083. Cell Rep. 2019. PMID: 31747604 Free article.
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Nishimura R, Tanaka Y, Koiwai K, Ishida K, Salsali A, Kaspers S, Kohler S, Lund SS. Nishimura R, et al. Among authors: Tanaka Y. Adv Ther. 2019 Oct;36(10):2769-2782. doi: 10.1007/s12325-019-01045-x. Epub 2019 Aug 23. Adv Ther. 2019. PMID: 31444706 Clinical Trial.
State-of-the-art treatment of systemic lupus erythematosus.
Tanaka Y. Tanaka Y. Int J Rheum Dis. 2020 Apr;23(4):465-471. doi: 10.1111/1756-185X.13817. Epub 2020 Mar 5. Int J Rheum Dis. 2020. PMID: 32134201 Free PMC article. Review.
[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, Oizumi T, Shikama Y, Tanaka Y, Okada S, Kim S, Kiyama T, Bando K, Shima K, Suzuki H, Takahashi T. Endo Y, et al. Among authors: Tanaka Y. Yakugaku Zasshi. 2020;140(1):63-79. doi: 10.1248/yakushi.19-00125. Yakugaku Zasshi. 2020. PMID: 31902887 Free article. Review. Japanese.
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
Nishiyama H, Yamamoto Y, Sassa N, Nishimura K, Fujimoto K, Fukasawa S, Yokoyama M, Enokida H, Takahashi K, Tanaka Y, Imai K, Shimamoto T, Perini R, Frenkl T, Bajorin D, Bellmunt J. Nishiyama H, et al. Among authors: Tanaka Y. Int J Clin Oncol. 2020 Jan;25(1):165-174. doi: 10.1007/s10147-019-01545-4. Epub 2019 Nov 15. Int J Clin Oncol. 2020. PMID: 31729625 Free PMC article. Clinical Trial.
An antiaromatic-walled nanospace.
Yamashina M, Tanaka Y, Lavendomme R, Ronson TK, Pittelkow M, Nitschke JR. Yamashina M, et al. Among authors: Tanaka Y. Nature. 2019 Oct;574(7779):511-515. doi: 10.1038/s41586-019-1661-x. Epub 2019 Oct 23. Nature. 2019. PMID: 31645731
12,016 results
Jump to page
Feedback